These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical experience with fosphenytoin in adults: pharmacokinetics, safety, and efficacy. Knapp LE; Kugler AR J Child Neurol; 1998 Oct; 13 Suppl 1():S15-8; discussion S30-2. PubMed ID: 9796747 [TBL] [Abstract][Full Text] [Related]
5. [Characteristics of drugs used in the treatment of acute convulsions and convulsive status]. Herranz JL; Argumosa A Rev Neurol; 2000 Oct 16-31; 31(8):757-62. PubMed ID: 11082886 [TBL] [Abstract][Full Text] [Related]
6. Valproate as a mainstay of therapy for pediatric epilepsy. Guerrini R Paediatr Drugs; 2006; 8(2):113-29. PubMed ID: 16608372 [TBL] [Abstract][Full Text] [Related]
7. Fosphenytoin for seizure control. Hutt N Am J Nurs; 1999 Mar; 99(3):52. PubMed ID: 10091570 [No Abstract] [Full Text] [Related]
8. Pharmacoeconomic considerations in treatment options for acute seizures. Graves N J Child Neurol; 1998 Oct; 13 Suppl 1():S27-9; discussion S30-2. PubMed ID: 9796750 [TBL] [Abstract][Full Text] [Related]
9. Advances in the medical treatment of epilepsy. Bazil CW; Pedley TA Annu Rev Med; 1998; 49():135-62. PubMed ID: 9509255 [TBL] [Abstract][Full Text] [Related]
10. Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study. Chen WB; Gao R; Su YY; Zhao JW; Zhang YZ; Wang L; Ren Y; Fan CQ Eur J Neurol; 2011 Dec; 18(12):1391-6. PubMed ID: 21557791 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977 [TBL] [Abstract][Full Text] [Related]
12. Fosphenytoin: a novel phenytoin prodrug. Boucher BA Pharmacotherapy; 1996; 16(5):777-91. PubMed ID: 8888074 [TBL] [Abstract][Full Text] [Related]
13. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients. Boucher BA; Feler CA; Dean JC; Michie DD; Tipton BK; Smith KR; Kramer RE; Young B; Parks BR; Kugler AR Pharmacotherapy; 1996; 16(4):638-45. PubMed ID: 8840370 [TBL] [Abstract][Full Text] [Related]
14. Intramuscular use of fosphenytoin: an overview. Uthman BM; Wilder BJ; Ramsay RE Neurology; 1996 Jun; 46(6 Suppl 1):S24-8. PubMed ID: 8649611 [TBL] [Abstract][Full Text] [Related]
15. Practical considerations in anticonvulsant therapy--Part 2. Meyer MC; Cloyd J; Garnett WR; Holmes GL; Schiffer JR Am Pharm; 1995 Sep; NS35(9):31-6, 40. PubMed ID: 7484814 [TBL] [Abstract][Full Text] [Related]
16. Intravenous valproate: onset and duration of anticonvulsant activity against a series of electroconvulsions in comparison with diazepam and phenytoin. Hönack D; Löscher W Epilepsy Res; 1992 Dec; 13(3):215-21. PubMed ID: 1493784 [TBL] [Abstract][Full Text] [Related]
17. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. de Silva M; MacArdle B; McGowan M; Hughes E; Stewart J; Neville BG; Johnson AL; Reynolds EH Lancet; 1996 Mar; 347(9003):709-13. PubMed ID: 8601999 [TBL] [Abstract][Full Text] [Related]
18. New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol. Bebin M; Bleck TP Drugs; 1994 Aug; 48(2):153-71. PubMed ID: 7527321 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of diazepam autoinjector for the management of epilepsy. Verrotti A; Milioni M; Zaccara G Expert Rev Neurother; 2015 Feb; 15(2):127-33. PubMed ID: 25614951 [TBL] [Abstract][Full Text] [Related]
20. Fosphenytoin sodium: new drug to replace intravenous phenytoin sodium. Voytko SM; Farrington E Pediatr Nurs; 1997; 23(5):503-6. PubMed ID: 9355589 [No Abstract] [Full Text] [Related] [Next] [New Search]